Haemonetics HAE
NYSE HAE
$117.07 -1.14 (-0.96%)
As of: Oct 21, 2026 · 3:59 PM EDT

Haemonetics (HAE) Long-Term Debt Issuances (2018 - 2026)

Updated

Haemonetics' Long-Term Debt Issuances came in at $300 million for fiscal Q4 2026 (quarter ended Mar 28, 2026).

Analysis

Haemonetics (HAE) Long-Term Debt Issuances (2018 - 2026) Analysis & Trends

Going back to fiscal Q1 2019, Haemonetics' Long-Term Debt Issuances data covers 5 quarters.

  • Long-Term Debt Issuances carries a five-year compound annual growth rate of -9.7% (FY2021 to FY2026).
  • Going back by fiscal year, Long-Term Debt Issuances was $700 million in FY2025 (+536.4%), $110 million in FY2024 (-60.7%) and $280 million in FY2023.
  • The fiscal Q4 2026 figure represents the highest quarterly Long-Term Debt Issuances since fiscal Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn -
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn -33.00 Mn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 6.56 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn -
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn -
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn -
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn -
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn -
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn -
10 Haemonetics 5.31 Bn 4.18 Bn 202.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 28, 2026 300.00 Mn
Mar 29, 2025 250.00 Mn
Jun 29, 2024 700.00 Mn
Dec 30, 2023 110.00 Mn
Apr 1, 2023 280.00 Mn
Jun 30, 2018 347.78 Mn
API Access

Haemonetics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=HAE&period=max&api_key=YOUR_API_KEY